Q4 2022 Pieris Pharmaceuticals Inc Earnings Call Transcript
Hello, and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Tom Bures. Please go ahead, sir.
Thanks, Kevin. Good morning, everyone, and thank you for joining us for our year-end 2022 conference call and corporate update. On the call today we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Hitto Kaufmann, our Chief Scientific Officer; Shane Olwill, our Chief Development Officer; and Mary Fitzgerald, Vice President, Project Leader for elarekibep, who will be available for Q&A. You can access the press release issued this morning on the Investor Relations page of our website at www.pieris.com.
Before we begin, I'd like to caution that comments made during this conference call may contain forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |